Insider Trading History of Sohail Faysal A.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Sohail Faysal A. since 2016. The trader's CIK number is 1425394. At the time of the last reporting, Sohail Faysal A. was the 10% Owner of Menlo Therapeutics Inc.. (stock ticker symbol MNLO). Also see all insider trading activities at Menlo Therapeutics Inc..

Note that in the past Sohail Faysal A. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Menlo Therapeutics Inc. (MNLO) by Sohail Faysal A.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 MNLO 0 $0 500,000 $3,825,000 0 $0

Yearly summary of insider trading at Neos Therapeutics, Inc. (NEOS) by Sohail Faysal A.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2016 NEOS 0 $0 78,335 $797,025 0 $0


Insider trading activities at 2 companies by Sohail Faysal A.:

1. Menlo Therapeutics Inc. (MNLO)

2. Neos Therapeutics, Inc. (NEOS)

Table 1. Insider trading of Menlo Therapeutics Inc. (MNLO) by Sohail Faysal A.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-07-24 MNLO Sale 500,000 7.65 3,825,000

Table 2. Insider trading of Neos Therapeutics, Inc. (NEOS) by Sohail Faysal A.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-04-20 NEOS Sale 8,540 9.88 84,409
2016-04-19 NEOS Sale 7,279 10.03 73,001
2016-04-18 NEOS Sale 4,548 10.10 45,934
2016-04-15 NEOS Sale 18,210 10.22 186,142
2016-04-14 NEOS Sale 27,066 10.29 278,563
2016-04-13 NEOS Sale 12,692 10.16 128,976

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sohail Faysal A. (10% Owner of Menlo Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.